About the Journal

Papers Sought by JID
JID Authors
JID Audience
JID Subject Sections
Interested in Submitting?
IDSA Family of Journals

The Journal of Infectious Diseases (JID) publishes bench-to-bedside or bedside-to-bench translational infectious diseases science—patient- and disease-focused research featuring a laboratory component. It provides a home for authors writing about mechanistic and translational research, seeking to put this research into context for clinical and experimental scientists as well as clinician readers. The editors welcome Major Articles and Brief Reports describing research results on microbiology, immunology, epidemiology, and related disciplines (e.g., AMR, microbiome) on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. See JID’s full list of subject sections.

JID does not publish papers that focus on descriptive clinical science; phase 3 or 4 clinical trials focused on clinical outcomes; clinical review papers; or case reports lacking laboratory investigation support. Such papers may be a better fit for our sister journals, Clinical Infectious Diseases and Open Forum Infectious Diseases.

With an Impact Factor of 5.0, the journal is ranked 15 out of 132 journals in the field of infectious diseases.

Papers Sought by JID

Translational Infectious Diseases Science

JID publishes papers featuring bench-to-bedside or bedside-to-bench infectious diseases research, namely, patient- and disease-focused research engaging laboratory science.

Early-Stage or Laboratory-Focused Clinical Trials

JID publishes phase 1 and 2 trials of novel drugs, vaccines and diagnostics, as well as later-stage trials with a laboratory-focused outcome.

Global Health

JID publishes global health and field science research testing hypotheses, supported by laboratory science.

Perspectives

JID publishes Perspective manuscripts on evolving, controversial or emerging infectious diseases topics, along with more general Perspectives on career development within the infectious diseases field.

Inclusion, Diversity, Access, and Equity (IDA&E)

JID welcomes papers and collections aimed at advancing the values and practice of IDA&E within the infectious diseases community.

Viewpoints

The JID Viewpoints section spotlights pithy, concise papers on topics involving complex or evolving infectious diseases science and scientific methodology.

Supplements

JID publishes supplements bringing together diverse groups of researchers around a topic of importance in translational infectious diseases science.

JID Authors

JID authors include infectious diseases laboratory-based scientists, microbiologists and clinical biologists, scientists of all backgrounds investigating topics relevant to infectious diseases, and infectious diseases pharmacists.

JID welcomes papers from early-career investigators, including infectious diseases fellows testing hypotheses (e.g., fellows working under K08, K23, or similar grants). The journal also welcomes authors from populations historically underrepresented in infectious diseases science and authors from low- and middle-income countries.

JID Audience

JID readers include infectious diseases clinical and laboratory-based scientists, microbiologists , clinicians interested in understanding disease mechanisms, scientists of all backgrounds investigating topics relevant to infectious diseases, and ID pharmacists.

JID Subject Sections

AMR
Bacteria
COVID-19
Fungi
Global Health
HIV/AIDS
Microbiome
Parasites
Pathogenesis and Host Response
Prions
Sexually Transmitted Infections
Special Reports
Viruses

Interested in Submitting?

Explore the benefits of publishing in JID, and ensure your research makes an impact in the field of infectious diseases by joining our author community.

Find out more

IDSA Family of Journals

IDSA publishes the premier society journals in infectious diseases. IDSA’s family of journals includes:

Clinical Infectious Diseases

Editor-in-Chief: Paul E. Sax, MD, is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School.

Clinical Infectious Diseases publishes practice-changing original research, reviews, guidelines, and perspectives that clinicians can use when caring for patients. CID covers the clinical presentation, diagnosis, treatment, and prevention of the full range of infectious diseases.

The Journal of Infectious Diseases

Editor-in-Chief: Cynthia L. Sears, MD, FIDSA, is Professor of Medicine, Oncology, and Molecular Microbiology and Immunology at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health and the Microbiome Program Leader of the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

The Journal of Infectious Diseases publishes bench-to-bedside or bedside-to-bench translational infectious diseases science—patient- and disease-focused research featuring a laboratory component. It provides a home for authors writing about mechanistic and translational research, seeking to put this research into context for clinical and experimental scientists as well as clinician readers.

Open Forum Infectious Diseases

Editor-in-Chief: Roger J. Bedimo, MD, is the Chief of Infectious Diseases Section at the VA North Texas Health Care System and Professor of Medicine at the University of Texas Southwestern Medical Center in Dallas.

Open Forum Infectious Diseases is a fully open-access journal that advances the field of infectious diseases by promoting the dissemination of high-quality research and fostering collaboration among practitioners, researchers, and policymakers. OFID’s goal is to provide a platform for the exchange of knowledge and ideas, spanning from the lab to the clinic, ultimately improving patient care and public health outcomes.

About the Journal